Sionna Therapeutics, Inc.
SIONCIK 0002036042 · last filing Jul 7, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
10,250 bought / 241,938 sold
net −231,688 sh · −$10.93M
- buys
- 1
- sells
- 3
- insiders active
- 4
Filing tape
Filed Tue, Jul 7, 2026
- −0 sh · $384.2K
Fitzpatrick Jennifer — Chief Legal Officer
- Exercised10,250Common Stock@ $6.11→ 10,250 held
- Sold10,250Common Stock@ $43.60→ 0 held
- Exercised10,250Non-Qualified Stock Option (right to buy)→ 40,685 held
Filed Thu, Jul 2, 2026
- −115,844 sh · $5.27M
Thompson Peter A. — Director
- Sold115,844Common Stock@ $45.50→ 2,555,877 held
- −115,844 sh · $5.27M
Orbimed Advisors LLC +1 — Director
- Sold115,844Common Stock@ $45.50→ 2,555,877 held
Insiders on this tape
- Fitzpatrick JenniferChief Legal Officer
- Thompson Peter A.Director
- Orbimed Advisors LLCDirector
- OrbiMed Capital GP VIII LLCDirector
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.